Maternal Mental Health Market Size & Growth Forecast 2026–2035, By Segments (Therapy, Disease Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Maternal Mental Health Market size was more than USD 12.46 Billion in 2025 and is set to grow at a 27.8% CAGR between 2026 and 2035, exceeding USD 144.82 Billion by 2035. The industry revenue for 2026 is assessed at USD 15.61 billion.

• Base Year Value (2025): USD 12.46 Billion
• CAGR (2026-2035): 27.8%
• Forecast Year Value (2035): USD 144.82 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Maternal Mental Health Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 44.45% of the market in 2025, supported by integrated diagnosis and referral pathways, greater provider awareness, and established reimbursement for ongoing maternal mental healthcare.
  • Asia Pacific is expected to expand at a 30.58% CAGR as healthcare access improves, screening becomes more integrated into maternal care, and increasing awareness brings more women into structured treatment.

• Segment Momentum:

  • IPT accounted for 28.19% of the market in 2025 due to its strong alignment with relationship changes, caregiving stress, and role transitions commonly experienced during pregnancy and postpartum periods.
  • Postpartum Depression is the fastest-growing indication because healthcare providers are placing greater emphasis on diagnosis and timely treatment, supported by increased recognition of its impact on mothers and infants.

• Market Expansion Drivers:

  • Rising prevalence of postpartum depression increasing demand for maternal mental health treatment services.
  • Expanding government funding and Medicaid coverage strengthening access to maternal mental healthcare.
  • Growing development of rapid-acting postpartum depression therapeutics accelerating commercial treatment adoption.

• Leading Market Participants:

  Key companies in the maternal mental health market include Therapy Mama (USA), Canopie Inc. (USA), Pfizer Inc. (USA), Viatris Inc. (USA), GSK plc (United Kingdom), Alembic Pharmaceuticals Ltd. (India), Mallinckrodt plc (USA), Sage Therapeutics, Inc. (USA), Bausch Health Companies Inc. (Canada), Magellan Health, Inc. (USA).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 12.46 Billion
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 144.82 Billion by 2035
  • Growth Forecasts: 27.8% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Interpersonal Psychotherapy (IPT) (Therapy) | Pregnancy and Postpartum General Anxiety (Disease Indication)
  • Emerging Opportunity Segment: Interpersonal Psychotherapy (IPT) (Therapy) | Postpartum Depression (Disease Indication)

Market Growth Drivers and Industry Trends

Rising prevalence of postpartum depression increasing demand for maternal mental health treatment services

As postpartum depression is identified more frequently through routine obstetric, pediatric, and primary care screening, a larger share of women are entering the care pathway rather than remaining undiagnosed, directly increasing demand for the maternal mental health market. This transition increases utilization of psychiatric consultations, therapy, digital support programs, and coordinated follow-up services during the postnatal period, while also pushing providers and health systems to formalize referral networks tied specifically to maternal care. In practice, the rising clinical burden changes purchasing and staffing decisions, with hospitals, clinics, and virtual care platforms expanding service capacity to manage sustained treatment needs rather than episodic emotional support.

Expanding government funding and Medicaid coverage strengthening access to maternal mental healthcare

Broader public funding and Medicaid reimbursement are removing one of the main barriers to treatment entry in the maternal mental health market by making screening, counseling, psychiatric care, and follow-up services financially accessible during pregnancy and the postpartum period. This has practical effects on provider participation and service availability, since reimbursement certainty encourages health systems, community clinics, and behavioral health groups to integrate maternal mental health into standard care pathways instead of treating it as a limited specialty offering. Coverage expansion also supports market penetration among lower-income and higher-risk populations, where unmet need has historically been high and where sustained payer support can translate into more consistent treatment engagement.

Growing development of rapid-acting postpartum depression therapeutics accelerating commercial treatment adoption

The emergence of rapid-acting therapies tailored to postpartum depression is reshaping treatment expectations in the maternal mental health market by addressing the need for faster symptom relief during a period when delays can affect maternal functioning, infant care, and family stability. That clinical value changes adoption behavior among prescribers, payers, and health systems, especially when conventional antidepressant pathways are seen as too slow or poorly matched to acute postpartum needs. It also broadens the commercial structure of the maternal mental health market beyond counseling and general psychiatric management, creating stronger incentives for diagnosis, specialist referral, formulary evaluation, and investment in treatment settings capable of administering newer postpartum-specific interventions.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of postpartum depression increasing demand for maternal mental health treatment services	2.20%	High	North America, Europe	High	Near Term
Expanding government funding and Medicaid coverage strengthening access to maternal mental healthcare	1.90%	High	North America	High	Mid Term
Growing development of rapid-acting postpartum depression therapeutics accelerating commercial treatment adoption	1.60%	High	North America, Europe	Emerging	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading position in 2025, accounting for a 44.45% share of the maternal mental health market. This leadership is bolstered by stronger diagnosis and referral pathways across obstetric, primary care, and behavioral health settings, which helps move patients into treatment earlier and more consistently than in less integrated systems. Wider provider awareness of postpartum depression, anxiety, and related conditions also sustains demand across screening, counseling, and medication-based care, while established reimbursement structures make ongoing care delivery more practical in routine clinical settings.

Asia Pacific is projected to expand at a 30.58% CAGR over the forecast period, driven by rising recognition of perinatal mental health needs and improving access to formal care. Growth in the maternal mental health market is being accelerated by the gradual integration of screening and support services into maternal care pathways, alongside broader expansion of healthcare infrastructure that brings more women into contact with trained providers. As treatment access improves and stigma begins to ease in clinical and urban care environments, more cases are being identified and managed through structured services rather than remaining unaddressed.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Low	Medium	Low	High	High
Regulatory Environment	Restrictive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Moderate	Strong	Moderate	Weak
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	High	Medium	Low
New Entrants / Startups	Dense	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

Key Country Insights

United States

Integrated Care Delivery

The U.S. maternal mental health market focuses on integrating behavioral health services into prenatal and postpartum care pathways. Healthcare providers across the U.S. continue expanding digital screening, telehealth access, and coordinated support for early intervention.

Japan

Early Screening Initiatives

Japan continues strengthening maternal mental health services through earlier psychological assessment and community-based follow-up. Healthcare organizations in Japan are expanding support programs that improve identification of postpartum mental health concerns within routine maternal care.

South Korea

Digital Support Networks

South Korea increasingly combines digital health platforms with maternal mental health services to improve patient engagement. Healthcare providers in South Korea are enhancing remote counseling and accessible monitoring tools that complement conventional clinical care.

Germany

Clinical Care Coordination

Germany emphasizes structured maternal mental health services supported by coordinated clinical care and standardized assessment practices. Healthcare providers in Germany continue strengthening multidisciplinary collaboration to improve continuity throughout pregnancy and postpartum recovery.

France

Preventive Maternal Services

France prioritizes preventive maternal mental health strategies through coordinated healthcare services and family support programs. Clinical providers in France continue integrating psychological evaluation into maternal care to encourage timely intervention and improved patient outcomes.

Italy

Community Care Expansion

Italy is expanding maternal mental health services through stronger collaboration between hospitals and community healthcare providers. Healthcare organizations in Italy increasingly emphasize accessible counseling and postpartum support to strengthen long-term maternal wellbeing.

Segment Leadership and Growth Trends

  Therapy Segment Analysis: Interpersonal Psychotherapy (IPT) (Largest & Fastest-Growing Segment)

Interpersonal Psychotherapy (IPT) held a 28.19% share of the maternal mental health market in 2025, reflecting its established role as a practical therapy option for women facing emotionally and socially driven mental health challenges during pregnancy and the postpartum period. Its leadership is aided by the strong fit between IPT and the relationship changes, caregiving stress, role transitions, and support-system disruptions that commonly shape maternal mental health needs. The same alignment is also driving continued growth in the maternal mental health market, as care providers increasingly favor approaches that can be applied in a structured and targeted way to address real-life interpersonal stressors without relying solely on medication-based intervention.

Disease Indication Segment Analysis: Pregnancy and Postpartum General Anxiety (Largest Segment) vs Postpartum Depression (Fastest-Growing Segment)

Within the maternal mental health market, Pregnancy and Postpartum General Anxiety accounted for a 36.31% share in 2025, making it the leading disease indication segment. Its large share is sustained by the broad and persistent nature of anxiety symptoms across both pregnancy and the postpartum period, when concerns around maternal health, childbirth, infant wellbeing, and changing family responsibilities frequently require ongoing clinical attention. This creates consistent demand for screening, counseling, and therapeutic support, helping the segment maintain its leadership position in routine maternal mental health care.

Postpartum Depression is emerging as the fastest-growing disease indication in the maternal mental health market as healthcare systems place greater emphasis on identifying and addressing depressive symptoms after childbirth. Its growth momentum is being reinforced by stronger recognition of the condition’s impact on both mother and infant outcomes, which is increasing the likelihood of diagnosis and treatment compared with less clearly defined emotional distress. Relative to other indications, postpartum depression is gaining traction because it is increasingly treated as a condition requiring direct and timely intervention rather than general postnatal adjustment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Therapy	Antidepressants, Interpersonal Psychotherapy (IPT), Cognitive Behavioral Therapy (CBT), Others	Interpersonal Psychotherapy (IPT)	Interpersonal Psychotherapy (IPT)
Disease Indication	Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others	Pregnancy and Postpartum General Anxiety	Postpartum Depression

Competitive Landscape and Market Positioning

Key companies in the maternal mental health market:

1. Therapy Mama (USA)

2. Canopie Inc. (USA)

3. Pfizer Inc. (USA)

4. Viatris Inc. (USA)

5. GSK plc (United Kingdom)

6. Alembic Pharmaceuticals Ltd. (India)

7. Mallinckrodt plc (USA)

8. Sage Therapeutics Inc. (USA)

9. Bausch Health Companies Inc. (Canada)

10. Magellan Health Inc. (USA)

The maternal mental health market is evolving with increasing focus on digital therapy platforms, remote counseling services, and accessible emotional support solutions for maternal care. Organizations are strengthening patient engagement initiatives and expanding integrated mental wellness programs to address rising awareness surrounding maternal health challenges. Technology-enabled support systems are becoming increasingly important in improving care accessibility and continuity.

Industry Development/News

Company Name	Date	Key Development
Seven Starling	Sep-25	The company secured $8 million in funding to scale its maternal mental health platform nationwide. This investment facilitates the expansion of its provider-integrated virtual behavioral health services, strengthening its digital care model and enhancing access to specialized mental health support during the pregnancy and postpartum periods.
LunaJoy	Apr-24	LunaJoy raised $4.2 million in funding to accelerate the expansion of its integrated maternal mental health program. The capital supports the nationwide rollout of provider-partnered behavioral health services, enabling the company to scale its clinical operations and increase capacity for digital mental health support for mothers.
Elevance Health	Feb-26	Elevance Health expanded its maternal mental health strategy by increasing access to doula services, coordinated care models, and digital health tools. This initiative focuses on improving continuity of care during and after pregnancy, strengthening community-based interventions, and embedding integrated behavioral health support into maternal care pathways.
UConn Health	May-26	UConn Health expanded its perinatal mental health programs to bolster integrated care for pregnant and postpartum patients in Connecticut. The initiative enhances behavioral health support within existing maternal care pathways, focusing on early intervention capabilities and addressing the rising demand for structured mental health services in clinical settings.
Blue Shield of California	May-25	Blue Shield of California prioritized integrated maternal behavioral health by expanding coordinated support services and perinatal mental health resources. The initiative addresses systemic gaps in treatment by embedding behavioral health care directly into maternal care pathways, improving early intervention and support for patients.
Blue Cross and Blue Shield of Illinois	Dec-25	The insurer utilized its Special Beginnings grant program to fund initiatives focused on reducing maternal and infant mortality rates. This program strengthens local health infrastructure and community-based support systems, directly impacting maternal mental and infant health outcomes across Illinois through targeted resource allocation.
Arthur M. Blank Family Foundation	Oct-24	The foundation awarded $2 million in grants to bolster maternal and infant mental health outcomes. This investment targets structural gaps in service delivery by enhancing caregiver support systems and early intervention programs, facilitating improved access to critical mental health resources in underserved communities.
East Carolina University	Jul-25	The institution’s MOTHeRS Project achieved national recognition for its telehealth-based solutions aimed at maternal mental health care in rural settings. The program optimizes service delivery through remote behavioral health interventions and integrated support models, providing a scalable framework for addressing mental health access disparities in rural populations.
Royal College of Psychiatrists	May-25	The organization identified significant risks to perinatal mental health service capacity due to funding constraints across Integrated Care Boards in England. This development highlights potential threats to service sustainability and equitable access to specialized perinatal psychiatric support, signaling a need for continued investment in public health infrastructure.
University of Denver	Feb-26	The university received a research grant from the Massage Therapy Foundation to conduct a three-year study on prenatal massage as a complementary intervention. This clinical research aims to assess the effectiveness of integrating non-traditional therapies into broader maternal mental health care frameworks, potentially informing future clinical practice guidelines.